Fall Clinical Dermatology

Clinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

At the 2022 Fall Clinical Dermatology Conference, a dermatologist shares results of using cemiplimab-rwlc (Libtayo) for basal and squamous cell carcinoma.

At the 2022 Fall Clinical Dermatology Conference, Bruce E. Strober, MD, PhD, reviewed the best treatment options for patients with psoriasis and psoriatic arthritis.

At the 2022 Fall Clinical Dermatology Conference, one clinician discusses history, definitions, and diagnosis for this common skin affliction.

At the 2022 Fall Clinical Dermatology Conference, 5 practitioners share their best tips for treating their patients

At the 2022 Fall Clinical Dermatology Conference, 3 expert clinicians share their strategies for diagnosing and managing alopecia areata.

At the 2022 Fall Clinical Dermatology Conference,a presenter looks at the best treatments for hair loss and nail fungus.

The 40-gene expression profile (40-GEP) test can focus treatment options and optimize patient outcomes, according to a poster presentation at the 2022 Fall Clinical Dermatology Conference.

At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.

Neal D. Bhatia, MD, discusses the nuances of photodynamic therapy in a session at Fall Clinical in Las Vegas, Nevada, October 20-23.

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, Aaron S. Farberg, MD, shares data on the treatment of plaque psoriasis using tildrakizumab-asmn.

At a session at the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss some of the top testing methods for skin cancer.

Aaron Farberg, MD, presents study data and efficacy of spesolimab for the treatment of generalized pustular psoriasis at the 2022 Fall Clinical Dermatology Conference.

At the 2022 Fall Clinical Dermatology Conference, a look at the latest treatments for monkeypox, HIV, and more.

At the 2022 Fall Clinical Dermatology Conference, Valerie D. Callender, MD, FAAD, presents “What’s Hot in Acne & Rosacea.”

Lisa Swanson, MD, FAAD, and James Q. Del Rosso, DO, FAOCD, FAAD, gave an in-depth discussion on Janus kinase (JAK) inhibitors for the management of atopic dermatitis at the 2022 Fall Clinical Dermatology Conference.

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

At the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss the best skin cleanser recommendations for their patients.

As the 2022 Fall Clinical Dermatology Conference begins this week, Heathy Ivy, DO, regional medical director for LaserAway in Atlanta, Georgia, shares why she is looking forward to attending Fall Clinical.

At the 2022 Fall Clinical Dermatology Conference in Las Vegas, a look at the latest technology for treating basal cell carcinoma and nonmelanoma skin cancer.

Matt Leavitt, DO, FAOCD, discusses highlights of his session on "Evalulating the Patient With Hair Loss" at this year's Fall Clinical conference in Las Vegas Nevada, October 20-23.

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Lisa Swanson, MD, FAAD, a pediatric dermatologist in Boise, Idaho, presents all that is new and hot in pediatric dermatology at the 2022 Fall Clinical Conference in Las Vegas Nevada, October 20-23.

Christopher Bunick, MD, shares highlights of his session from the 2022 Fall Clinical conference in Las Vegas, Nevada, October 20-23.

The 2022 Fall Clinical Dermatology Conference begins today in Las Vegas, Nevada, and continues through October 23rd.

Skin sensitivity will be a factor in vehicles for new treatments.

Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.

FDA approval of ruxolitinib (Opzelura, Incyte) adds the first new topical anti-inflammatory to the atopic dermatitis (AD) armamentarium in 50 years, but boxed warnings raise questions.

Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.